Log in to save to my catalogue

Development of a robust blood‐based multi‐pathway biomarker assay for early screening and classifica...

Development of a robust blood‐based multi‐pathway biomarker assay for early screening and classifica...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11716282

Development of a robust blood‐based multi‐pathway biomarker assay for early screening and classification of Alzheimer’s disease

About this item

Full title

Development of a robust blood‐based multi‐pathway biomarker assay for early screening and classification of Alzheimer’s disease

Publisher

Hoboken: John Wiley and Sons Inc

Journal title

Alzheimer's & dementia, 2024-12, Vol.20 (S2), p.n/a

Language

English

Formats

Publication information

Publisher

Hoboken: John Wiley and Sons Inc

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Background
Alzheimer's disease (AD) is a devastating neurodegenerative disease with delayed diagnosis until the manifestation of symptoms. Although the emergence of blood‐based biomarkers offers hope for easy detection of AD, existing AD‐associated blood biomarkers, known as the “blood ATN biomarkers”, mainly capture the pathological hallmarks o...

Alternative Titles

Full title

Development of a robust blood‐based multi‐pathway biomarker assay for early screening and classification of Alzheimer’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11716282

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11716282

Other Identifiers

ISSN

1552-5260

E-ISSN

1552-5279

DOI

10.1002/alz.086053

How to access this item